Clinical High Risk For Psychosis
📧 Sign up to get email alerts when something new happens for Clinical High Risk For Psychosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Mobile Thinking Intervention: A Inital Test [NA]
This clinical trial update describes a preliminary test of a mobile thinking intervention for individuals with schizophrenia and those at cl…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication [NA]
This clinical trial update from Icahn School of Medicine at Mount Sinai investigates reducing the duration of untreated psychosis in the Uni…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Digital Strategies to Advance Help-Seeking Aim 1 and 2
A Columbia University-led clinical trial is testing digital strategies to improve help-seeking among individuals at clinical high risk for p…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis [NA]
A ClinicalTrials.gov study update describing Digital Dialectical Behavioural Therapy for youth at clinical high risk for psychosis; the stud…
-
CLINICAL_TRIALS research · 2024-04-01Clinical Trial Update: Feasibility of an Early Detection Program for Early Psychosis on a College Campus
A completed clinical trial evaluating the feasibility of an early detection program for early psychosis on a college campus, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Gabapentin in Patients at Clinical Risk for Psychosis [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of gabapentin in individuals at clinical high risk for psychosis was terminated; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Glutamate Reducing Interventions in Schizophrenia [Phase 1]
Phase 1 clinical trial update evaluating glutamate-reducing interventions for individuals at clinical high risk for psychosis; study complet…